Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China flag China · Delayed Price · Currency is CNY
10.31
+0.08 (0.78%)
At close: Feb 3, 2026

SHA:600267 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,5171,4981,5871,3991,2962,059
Trading Asset Securities
2.47-0.29-3.050.36
Cash & Short-Term Investments
1,5191,4981,5871,3991,2992,059
Cash Growth
2.37%-5.63%13.45%7.70%-36.93%15.43%
Accounts Receivable
1,9181,9182,0662,5532,2391,918
Other Receivables
170.07203.59411.65249.57414.04334.8
Receivables
2,0882,1222,4782,8022,6532,253
Inventory
1,6801,7951,9571,9142,0232,565
Other Current Assets
337.53247.25337.33294.12389.29470.34
Total Current Assets
5,6255,6616,3596,4096,3647,348
Property, Plant & Equipment
7,1437,5668,2529,1019,75410,369
Long-Term Investments
1,4191,4501,4151,4821,3831,299
Goodwill
----1.421.42
Other Intangible Assets
877.95946.661,0731,3371,419734.35
Long-Term Deferred Tax Assets
157.11175.22179.6296.17118.58198.3
Long-Term Deferred Charges
4.8653.28176.26194.45187.17621.84
Other Long-Term Assets
90.16119.68159.02158.75146.69288.01
Total Assets
15,31815,97217,61318,77819,37420,860
Accounts Payable
1,1211,0791,1441,3031,0371,355
Accrued Expenses
460.241,4091,6121,5851,6171,259
Short-Term Debt
2,0712,1612,1573,0054,4915,112
Current Portion of Long-Term Debt
879.76908.831,048313.86557.011,971
Current Portion of Leases
-14.6510.6910.7511.64-
Current Income Taxes Payable
185.7459.2834.7459.8344.95111.97
Current Unearned Revenue
133.2691.49106.5119.05268.42248.35
Other Current Liabilities
1,085414.08469.87736.82757.82472.84
Total Current Liabilities
5,9366,1386,5847,1338,78510,530
Long-Term Debt
411.321,0072,3683,0572,7581,088
Long-Term Leases
47.2758.3129.1532.3837.56-
Long-Term Unearned Revenue
142.09164.58185.96207.15216.28249.01
Long-Term Deferred Tax Liabilities
25.5125.2522.6317.9720.7375.02
Other Long-Term Liabilities
--74.08-211.12661.12
Total Liabilities
6,5627,3939,26410,44812,02912,603
Common Stock
1,1991,1991,2081,1981,196965.53
Additional Paid-In Capital
4,2974,2914,3464,1633,5113,633
Retained Earnings
3,3533,1382,5362,8292,5002,031
Treasury Stock
-350.17-299.4-341.15-549.56-337.73-
Comprehensive Income & Other
11.813.12353.08439.19433.9849.69
Total Common Equity
8,5108,3418,1028,0797,3036,679
Minority Interest
244.79237.66247.44251.142.231,578
Shareholders' Equity
8,7558,5798,3498,3307,3468,257
Total Liabilities & Equity
15,31815,97217,61318,77819,37420,860
Total Debt
3,4094,1505,6136,4197,8558,171
Net Cash (Debt)
-1,890-2,652-4,026-5,020-6,556-6,111
Net Cash Per Share
-1.64-2.27-3.46-4.31-5.79-6.30
Filing Date Shares Outstanding
1,1631,1691,1781,1881,196965.53
Total Common Shares Outstanding
1,1631,1691,1891,1721,196965.53
Working Capital
-310.89-476.51-224.79-723.95-2,421-3,182
Book Value Per Share
7.327.146.816.896.116.92
Tangible Book Value
7,6337,3957,0296,7425,8835,943
Tangible Book Value Per Share
6.566.335.915.754.926.16
Buildings
-6,0325,9695,6695,6085,472
Machinery
-9,1658,6608,4458,1157,648
Construction In Progress
-216.84688.391,2441,5412,270
Source: S&P Global Market Intelligence. Standard template. Financial Sources.